
Among two primary types of lung cancers, Small cell lung cancer is a rare and rapidly spreading type. While anyone might be affected, those who have smoked tobacco for a long time are usually the ones who are affected.
Type of Small Cell Lung Cancer (SCLC)
There are two major types of SCLC
What is the Importance of Timely Treatment?
Timely treatment of Small Cell Lung Cancer (SCLC) is essential for several reasons:
Small Cell Lung Cancer (SCLC) is better known for its aggressiveness and rapid progression. Here are some common symptoms:
Although smoking is the leading cause of small cell lung cancer (SCLC), there are several other risk factors to take into account.
Chemotherapy with drugs is the main treatment for small cell lung cancer (SCLC) in Malaysia. For better results, immunotherapy drugs are frequently included. Topotecan is used as a second-line treatment; newer medications such are demonstrating promise in clinical trials. Additionally, Malaysia is actively engaged in international research, taking part in clinical trials to investigate new treatment options and raise SCLC patient survival rates.
There are a few things you can do to lower your risk of developing Small Cell Lung Cancer (SCLC), particularly of the bladder, even if it is not always preventable:
Treatment options for Small Cell Lung Cancer (SCLC) differ based on the type and stage of the disease and the patient's overall health. The following are a few current treatments:
Lobectomy: Elimination of a lung lobe. The most popular procedure for SCLC in its early stages is this one.
Wedge Resection: This removes a small section of the tumour.
Segmentectomy: This is the Removal of a more prominent lung segment but not the entire lobe. Usually, this is applied to individuals with lung impairment or early-stage cancer.
Radiation Therapy: Treatments using high-energy rays to target cancer cells and reduce tumour size are known as radiation therapy. It may be used in combination with chemotherapy for Small Cell Lung Cancer (SCLC) or to relieve symptoms in advanced-stage SCLC.
Targeted Therapy : Drugs designed for particular forms of lung cancer are used in this treatment. Targeted therapy can locate and target specific cancer cells without endangering healthy cells. Although SCLC usually doesn't exhibit specific mutations like SCLC, studies are still being conducted on targeted treatments for particular genetic changes.
Cost Start From USD 2000 - USD 10000Explore Options
Immunotherapy : It emerged as a potentially effective treatment for SCLC, particularly for patients with advanced stages of the disease or who experience a relapse following chemotherapy. The body's immune system can better identify and combat cancer cells through immunotherapy.
Cost Start From USD 15000 - USD 50000Explore Options
Chemotherapy : Chemotherapy uses medications that target lung cancer. It is among the most widely used therapies for SCLC. Chemotherapy may be prescribed by your oncologist alone or in conjunction with other treatments.
Cost Start From USD 1500 - USD 3500Explore Options
A variety of imaging tests, biopsies, and other techniques are used in the diagnosis of small cell lung cancer (SCLC) to detect and stage the malignancy. These are a few typical diagnostic choices:
Imaging Studies
Biopsy
Laboratory Tests
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
Lifestyle changes and modification
Dietary adjustments and supplements shall make lifestyle changes and tailored meal plans to control symptoms and guarantee adequate nourishment. The practice of yoga and meditation helps reduce stress and improve mental well-being.
Lymphedema Management
Lymphatic drainage exercises promote lymphatic fluid flow away from the affected area. Our graded exercise programs allow patients to lead a dignified lifestyle.
Monitoring and follow-up
Schedule regular follow-up appointments with the oncologist to address complications, monitor recovery, and detect any signs of recurrence.
Depending on the circumstances, your doctor might recommend medication to help manage your symptoms and complement the course of treatment.









Kuala Lumpur, Malaysia
Sunway Medical Centre has initiated a comprehensive expansion plan close to its current hospital facility to enhance its ability to provide services to the global market. The new Cancer Radiosurgery Center and Nuclear Medicine Center, which will also house additional Centers of Excellence like the Digestive Health Center and Dialysis Center, marked the completion of Tower C's first phase in October 2016.

Kuala Lumpur, Malaysia
Prince Court is a private medical facility in the center of Kuala Lumpur that has 277 individual beds. Our dedication is to provide you with the best treatment possible from the time you arrive until you depart, healthier and happier. We are well-known for our top-notch facilities, cutting-edge technology, and friendly customer service.

Kuala Lumpur, Malaysia
Subang Jaya Medical Center is renowned for pioneering radiation oncology treatments and infrastructure in Malaysia. The hospital also has a state-of-the-art Cancer Radiosurgery Centre (CRC), which is fully furnished with the latest medical technology for cancer detection, monitoring, and treatment.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
The time needed to treat small cell lung cancer (SCLC) varies in Malaysia depending on the disease stage and selected treatments. Speaking with an oncologist is crucial to establish a customised treatment schedule.
In Malaysia, a comprehensive strategy is used to manage the quality of life during and after small cell lung cancer (SCLC) treatment. This comprises programs for pulmonary rehabilitation aimed at improving physical function and general well-being, as well as psychological support and symptom management.
It is challenging to get precise success rates for treating non-small cell lung cancer (NSCLC) in Malaysia. However, depending on the stage of diagnosis, 5-year survival rates vary significantly across the globe.
About 10% of all malignancies in Malaysia are lung cancers, making them a major cause of cancer-related mortality. About 80% of these cases are Non-Small Cell Lung Cancer (NSCLC), with a 5-year relative survival rate of only 11% due to the fact that a large percentage of these cases are detected at advanced stages.
In Malaysia, it is traditional practice to get a second opinion. Many hospitals and oncologists are willing to assess cases and offer second opinions on treatment strategies. One can:
Malaysia is a cost-effective choice for those seeking treatment because it provides top-notch medical care at affordable costs compared to several Western nations.
Malaysia's healthcare system accepts patients from abroad and provides excellent SCLC treatments at many clinics and hospitals.